Glaxo’s New Research Chief Loves Big Pharma. Now He Has To Fix It

GlaxoSmithCline is turning to a new chief scientific officer, Hal Barron, to reinvigorate its drug pipeline.

Read the full post on Forbes - Healthcare

Matthew Herper, Forbes Staff